Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (541-550 of 651) with videos related to

Pageof 66
Sort By:
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Blood|January 14, 2010
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasmsNils H Thoennissen, Utz O Krug, Dhong Hyun Tony Lee, et al.
Blood|August 3, 2007
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alphaSteffen Koschmieder, Francesco D'Alò, Hanna Radomska, et al.
Blood|May 26, 2010
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemiaCarsten Müller-Tidow, Hans-Ulrich Klein, Antje Hascher, et al.
Blood|May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AMLSwati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
Annals of Hematology|October 24, 2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative GroupEva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, et al.
Cancer Discovery|March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/VenetoclaxAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Blood|November 5, 2025
Dynamic rRNA Methylation Regulates Translation in the Hematopoietic System and is Essential for Stem Cell FitnessOfri Rabany, Sivan Ben Dror, Maram Arafat, et al.
Bone Marrow Transplantation|December 5, 2024
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myelomaNora Grieb, Alexander Oeser, Maximilian Ferle, et al.
Nature Genetics|September 24, 2021
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expressionHaiyang Yun, Nisha Narayan, Shabana Vohra, et al.
Pageof 66

Showing results (541-550 of 651) with videos related to

Sort By:
Pageof 66
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Blood|January 14, 2010
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasmsNils H Thoennissen, Utz O Krug, Dhong Hyun Tony Lee, et al.
Blood|August 3, 2007
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alphaSteffen Koschmieder, Francesco D'Alò, Hanna Radomska, et al.
Blood|May 26, 2010
Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemiaCarsten Müller-Tidow, Hans-Ulrich Klein, Antje Hascher, et al.
Blood|May 12, 2019
Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AMLSwati Garg, Armando Reyes-Palomares, Lixiazi He, et al.
Annals of Hematology|October 24, 2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative GroupEva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, et al.
Cancer Discovery|March 9, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/VenetoclaxAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Blood|November 5, 2025
Dynamic rRNA Methylation Regulates Translation in the Hematopoietic System and is Essential for Stem Cell FitnessOfri Rabany, Sivan Ben Dror, Maram Arafat, et al.
Bone Marrow Transplantation|December 5, 2024
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myelomaNora Grieb, Alexander Oeser, Maximilian Ferle, et al.
Nature Genetics|September 24, 2021
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expressionHaiyang Yun, Nisha Narayan, Shabana Vohra, et al.
Pageof 66